La filiale de China Medical System a signé un accord de novation. China Medical System's subsidiary signed a Novation Agreement.

China Medical System (00867) a annoncé le 3 février 2024 que sa filiale en propriété exclusive avait conclu un accord de novation avec Vifor Fresenius Medical Care Renal Pharma Ltd. et Winhealth Investment pour les comprimés à croquer d'oxyhydroxyde sucroferrique Velphoro®. China Medical System (00867) announced on February 3, 2024, that its wholly-owned subsidiary entered into a Novation Agreement with Vifor Fresenius Medical Care Renal Pharma Ltd. and Winhealth Investment for the sucroferric oxyhydroxide chewable tablets Velphoro®. L'accord de licence entre Winhealth Investment et VFMCRP a été signé le 28 juin 2023, accordant à Winhealth Investment une licence exclusive pour enregistrer, importer, promouvoir, distribuer, utiliser et vendre le produit en Chine continentale, à Hong Kong, Macao et Taiwan. The License Agreement between Winhealth Investment and VFMCRP was signed on June 28, 2023, granting Winhealth Investment an exclusive license to register, import, promote, distribute, use, and sell the product in Mainland China, Hong Kong, Macao, and Taiwan.

February 04, 2024

4 Articles